Company intelligence / Profile preview

DocMed

Ownership: Private
Development stage: Other

Overview

DocMed operates the largest B2B online pharmaceutical marketplace in Singapore and is the first HSA licensed e-pharmacy for direct delivery to patients. It offers over 5,000 SKUs of pharmaceuticals and medical supplies, maintains the largest database of healthcare practitioners in ASEAN, and provides digital tools for prescription fulfillment and data analytics. The company serves clinics, pharmacies, hospitals, nursing homes, and trade partners across Southeast Asia.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Metro ARC Investments

Beyond the preview

Go deeper on DocMed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on DocMed.

Explore the full profile